Moolec Science SA (MLECW)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 06-30. Amounts in USD.

Revenue TTM

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Gross Profit TTM

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Income TTM

-9M -6M -3M 0 3M 6M 9M Q2 '23: -7.5M Q3 '23: -7.4M Q4 '23: -6.7M Q1 '24: -8.2M Q2 '24: -5.1M Q2 '23 Q3 '23 Q4 '23 Q1 '24 Q2 '24

Net Income TTM

-120M -80M -40M 0 40M 80M 120M Q2 '23: 42.3M Q3 '23: 41.5M Q4 '23: -51.8M Q1 '24: -52.7M Q2 '24: -103.8M Q2 '23 Q3 '23 Q4 '23 Q1 '24 Q2 '24

Cost of Revenue TTM

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Cash Flow TTM

-15M -10M -5M 0 5M 10M 15M Q2 '23: -1.6M Q3 '23: -5.5M Q4 '23: -7.5M Q1 '24: -9.3M Q2 '24: -12.6M Q2 '23 Q3 '23 Q4 '23 Q1 '24 Q2 '24

Free Cash Flow TTM

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Shares Outstanding Quarterly

0 15M 30M 45M Q3 '22: 31M Q1 '23: 31M Q3 '23: 37.6M Q1 '24: 37.8M Q2 '24: 37.8M Q2 '25: 39M Q3 '22 Q1 '23 Q3 '23 Q1 '24 Q2 '24 Q2 '25

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.